secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001104659-25-073163
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics enters $1B accelerated share repurchase agreements with Citibank
--------------------------------------------------------------------------------

- Two ASR agreements with Citibank: $500M uncollared and $500M collared; total upfront payment $1B due Aug 4, 2025.
- Uncollared ASR: initial delivery ~1.27M shares (75% of expected); final settlement expected Q4 2025 based on VWAP less discount.
- Collared ASR: initial delivery ~850K shares (50% of expected); additional delivery after hedging; final settlement expected Q1 2026 with collar.
- At July 30, 2025, company had ~45.2M shares outstanding; CEO cites confidence in intrinsic value and cash flow generation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465925073163/0001104659-25-073163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465925073163/tm2522276d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-073163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer